Aug 06, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q1 FY25 conference call of Gland Pharma Limited. (Operator instructions) Please note that this conference is being recorded.
I now hand the conference over to Ankit from Gland. Thank you, and over to you, Ankit.
Unidentified Corporate Representative
Thank you, Sagar. Good evening, everyone, and we welcome you to Gland Pharma earnings conference call for Q1 FY25. My name is Ankit, and I head investments, M&A and corporate strategy at Gland. Joining me today on the call are Mr. Srinivas Sadu, our Executive Chairman and CEO; Mr. Alain, the Chief Executive Officer of Cenexi, our European CDMO business; and Mr. Ravi Mitra, our CFO.
Together today, we'll discuss our business performance and address any questions that you may have. We will begin with the business highlights and Mr. Sadu followed by an overview of the Cenexi's performance from Alain,.And lastly, the Group financial review by Ravi.
Before we proceed, I'd like to remind everyone that some of the statements made today will be
Q1 2025 Gland Pharma Ltd Earnings Call Transcript
Aug 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers